@Article{Wierzbicka2017,
journal="Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii",
issn="1230-2813",
volume="26",
number="3",
year="2017",
title="REM behaviour sleep disorder – case study",
abstract=" Purpose : REM behaviour sleep disorder (RBD) is a parasomnia and involves sudden movements and/or vocalizations that reflect the  dream content. This disorder is a  common symptom of  neurodegenerative diseases or their prodromal symptom. Until recently, clonazepam was the  most commonly used drug to relieve symptoms of  RBD. The  aim of  the  article is to describe successful RBD treatment with melatonin.   Case description:   A case of  a 56-year-old man with a  history of  symptoms characteristic for  RBD was presented. The  initial diagnosis was confirmed by video-polysomnography in  the  course of  which clinical episodes and periods of  muscle atonia during REM sleep were recorded. The  cause of  RBD was not identified, an  idiopathic form of  the  disorder was diagnosed. Melatonin was used for treatment in  the  target dose of  5 mg/day with a  satisfactory result. Due to an  increased risk of  a neurodegenerative disease, the  patient remained under care of  a neurologist.    Comment:   Due to more frequently reported effectiveness of  melatonin in  RBD treatment with a  low risk of  adverse reactions and interactions with other drugs, it is worth considering its use before the  decision to administer clonazepam, especially in  the  elderly.",
author="Wierzbicka, Aleksandra
and Szaulińska, Katarzyna
and Poradowska, Ewa
and Jernajczyk, Wojciech
and Wichniak, Adam",
pages="194--202",
doi="10.5114/ppn.2017.70551",
url="http://dx.doi.org/10.5114/ppn.2017.70551"
}